CIK 0001427570 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- 4 Open-market sale Chief Financial Officer sold 418 shares at an average $8.87 ($3,708)
- 4 Open-market sale Chief Financial Officer sold 372,113 shares at an average $0.17 ($62,938)
- 4 Open-market sale Chief Financial Officer sold 8,393 shares at an average $0.27 ($2,287)
- 4 Open-market sale CFO sold 8,293 shares at an average $0.28 ($2,329)
- 4 Open-market sale Chief Financial Officer sold 4,828 shares at $0.39 ($1,883)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 4,728 shares at $0.47 ($2,222)
- 4 Open-market sale President and CEO sold 11,674 shares at $0.47 ($5,487)
- 4 Open-market sale Chief Financial Officer sold 4,630 shares at $0.55 ($2,547)
- 4 Open-market sale President and CEO sold 11,442 shares at $0.55 ($6,293)
- 4 Open-market sale President and CEO sold 11,309 shares at an average $0.95 ($10,771)
- 4 Open-market sale Chief Financial Officer sold 4,478 shares at $0.96 ($4,299)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $0.92 ($18,422)
- 4 Open-market sale President and CEO sold 11,417 shares at $0.77 ($8,791)
- 4 Open-market sale Chief Financial Officer sold 4,529 shares at $0.77 ($3,487)
- 4 Open-market sale Chief Financial Officer sold 5,038 shares at $1.13 ($5,693)
- 4 Open-market sale President and CEO sold 11,063 shares at $1.13 ($12,501)
- 4 Open-market sale CFO sold 3,658 shares at $1.06 ($3,877)
- 4 Open-market sale President and CEO sold 6,538 shares at $1.06 ($6,930)
- 4 Open-market sale President and CEO sold 8,324 shares at $1.22 ($10,155)
Page 2 of 13 · 243 filings